Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neoantigen Targeted Therapies market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neoantigen Targeted Therapiesmarket, defines the market attractiveness level of Neoantigen Targeted Therapies market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neoantigen Targeted Therapies industry, describes the types of Neoantigen Targeted Therapies market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neoantigen Targeted Therapies market and the development prospects and opportunities of Neoantigen Targeted Therapies industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neoantigen Targeted Therapies market in Chapter 13.
By Player:
Immunovative Therapies
Immunicum
Gradalis
Bavarian Nordic
Precision Biologics
Genocea Biosciences
Iovance Biotherapeutics
Vaxon Biotech
Medigene
Neon Therapeutics
By Type:
Monotherapy
Combination Therapy
By End-User:
Medical Research Institution
Hospital and Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neoantigen Targeted Therapies Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neoantigen Targeted Therapies Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neoantigen Targeted Therapies Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neoantigen Targeted Therapies Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neoantigen Targeted Therapies Market Analysis and Outlook to 2022
-
7.1 Global Neoantigen Targeted Therapies Consumption (2017-2022)
-
7.2 United States Neoantigen Targeted Therapies Consumption (2017-2022)
-
7.3 Europe Neoantigen Targeted Therapies Consumption (2017-2022)
-
7.4 China Neoantigen Targeted Therapies Consumption (2017-2022)
-
7.5 Japan Neoantigen Targeted Therapies Consumption (2017-2022)
-
7.6 India Neoantigen Targeted Therapies Consumption (2017-2022)
-
7.7 South Korea Neoantigen Targeted Therapies Consumption (2017-2022)
8 Region and Country-wise Neoantigen Targeted Therapies Market Analysis and Outlook to 2028
-
8.1 Global Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
8.2 United States Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
8.3 Europe Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
8.4 China Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
8.5 Japan Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
8.6 India Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
-
8.7 South Korea Neoantigen Targeted Therapies Consumption Forecast (2022-2028)
9 Global Neoantigen Targeted Therapies Market Outlook by Types and Applications to 2022
-
9.1 Global Neoantigen Targeted Therapies Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Combination Therapy Consumption and Growth Rate (2017-2022)
-
9.2 Global Neoantigen Targeted Therapies Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Medical Research Institution Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital and Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Neoantigen Targeted Therapies Market Outlook by Types and Applications to 2028
-
10.1 Global Neoantigen Targeted Therapies Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Combination Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neoantigen Targeted Therapies Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Medical Research Institution Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital and Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Neoantigen Targeted Therapies Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neoantigen Targeted Therapies Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neoantigen Targeted Therapies Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neoantigen Targeted Therapies Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neoantigen Targeted Therapies Market Competitive Analysis
-
14.1 Immunovative Therapies
-
14.1.1 Immunovative Therapies Company Details
-
14.1.2 Immunovative Therapies Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Immunovative Therapies Neoantigen Targeted Therapies Product and Service
-
14.2 Immunicum
-
14.2.1 Immunicum Company Details
-
14.2.2 Immunicum Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Immunicum Neoantigen Targeted Therapies Product and Service
-
14.3 Gradalis
-
14.3.1 Gradalis Company Details
-
14.3.2 Gradalis Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Gradalis Neoantigen Targeted Therapies Product and Service
-
14.4 Bavarian Nordic
-
14.4.1 Bavarian Nordic Company Details
-
14.4.2 Bavarian Nordic Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bavarian Nordic Neoantigen Targeted Therapies Product and Service
-
14.5 Precision Biologics
-
14.5.1 Precision Biologics Company Details
-
14.5.2 Precision Biologics Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Precision Biologics Neoantigen Targeted Therapies Product and Service
-
14.6 Genocea Biosciences
-
14.6.1 Genocea Biosciences Company Details
-
14.6.2 Genocea Biosciences Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Genocea Biosciences Neoantigen Targeted Therapies Product and Service
-
14.7 Iovance Biotherapeutics
-
14.7.1 Iovance Biotherapeutics Company Details
-
14.7.2 Iovance Biotherapeutics Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Iovance Biotherapeutics Neoantigen Targeted Therapies Product and Service
-
14.8 Vaxon Biotech
-
14.8.1 Vaxon Biotech Company Details
-
14.8.2 Vaxon Biotech Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Vaxon Biotech Neoantigen Targeted Therapies Product and Service
-
14.9 Medigene
-
14.9.1 Medigene Company Details
-
14.9.2 Medigene Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Medigene Neoantigen Targeted Therapies Product and Service
-
14.10 Neon Therapeutics
-
14.10.1 Neon Therapeutics Company Details
-
14.10.2 Neon Therapeutics Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Neon Therapeutics Neoantigen Targeted Therapies Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neoantigen Targeted Therapies
-
Figure Neoantigen Targeted Therapies Picture
-
Table Global Neoantigen Targeted Therapies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neoantigen Targeted Therapies Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neoantigen Targeted Therapies Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neoantigen Targeted Therapies Consumption by Country (2017-2022)
-
Figure United States Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Table Europe Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure China Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Japan Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure India Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neoantigen Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Neoantigen Targeted Therapies Consumption Forecast by Country (2022-2028)
-
Figure United States Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neoantigen Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Combination Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Research Institution Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital and Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Monotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Combination Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Research Institution Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital and Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neoantigen Targeted Therapies Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neoantigen Targeted Therapies Export by Region (Top 5 Countries) (2017-2028)
-
Table Immunovative Therapies (Foundation Year, Company Profile and etc.)
-
Table Immunovative Therapies Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Immunovative Therapies Neoantigen Targeted Therapies Product and Service
-
Table Immunicum (Foundation Year, Company Profile and etc.)
-
Table Immunicum Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Immunicum Neoantigen Targeted Therapies Product and Service
-
Table Gradalis (Foundation Year, Company Profile and etc.)
-
Table Gradalis Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gradalis Neoantigen Targeted Therapies Product and Service
-
Table Bavarian Nordic (Foundation Year, Company Profile and etc.)
-
Table Bavarian Nordic Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bavarian Nordic Neoantigen Targeted Therapies Product and Service
-
Table Precision Biologics (Foundation Year, Company Profile and etc.)
-
Table Precision Biologics Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Precision Biologics Neoantigen Targeted Therapies Product and Service
-
Table Genocea Biosciences (Foundation Year, Company Profile and etc.)
-
Table Genocea Biosciences Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genocea Biosciences Neoantigen Targeted Therapies Product and Service
-
Table Iovance Biotherapeutics (Foundation Year, Company Profile and etc.)
-
Table Iovance Biotherapeutics Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Iovance Biotherapeutics Neoantigen Targeted Therapies Product and Service
-
Table Vaxon Biotech (Foundation Year, Company Profile and etc.)
-
Table Vaxon Biotech Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vaxon Biotech Neoantigen Targeted Therapies Product and Service
-
Table Medigene (Foundation Year, Company Profile and etc.)
-
Table Medigene Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medigene Neoantigen Targeted Therapies Product and Service
-
Table Neon Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Neon Therapeutics Neoantigen Targeted Therapies Sales, Price, Value and Gross Profit (2017-2022)
-
Table Neon Therapeutics Neoantigen Targeted Therapies Product and Service
-
